Baird has lowered its rating on Caterpillar to Neutral from Outperform, citing growing state and local regulations that could slow demand for its power generation equipment from the booming data center sector.
The automotive supplier secured a new business award for its electrically assisted turbocharger technology for a hybrid passenger vehicle, with production slated to begin in 2029.
The environmental technology company's stock gained after announcing two new air pollution control contracts with industrial clients, bringing its year-to-date bookings to $12.6 million.
The U.S. FDA has accepted PolyPid's New Drug Application for its post-surgical infection prevention drug, D-PLEX100, and granted it Priority Review, setting a target action date of November 28, 2026.
JPMorgan strategists predict the U.S. Treasury will postpone changes to its bond sale guidance in its upcoming quarterly refunding to avoid unsettling markets ahead of the November midterm elections.
Chinese memory chip maker ChangXin Memory Technologies (CXMT) surged over 466% in its trading debut, achieving a massive valuation and triggering a sharp sell-off in global semiconductor giants like Samsung, SK Hynix, and ASML.
Allogene Therapeutics (ALLO) stock climbed after the FDA granted Regenerative Medicine Advanced Therapy and Fast Track designations to its experimental lymphoma therapy, cema-cel, based on positive trial data.
Shares of automotive supplier BorgWarner gained after the company announced a significant new contract to supply its eTurbo technology for a major European automaker's hybrid vehicles, with production set for 2029.
Major U.S. technology companies are issuing unprecedented levels of debt to fund artificial intelligence expansion, leading to higher borrowing costs and wider credit spreads as the market shows signs of fatigue.
